WP5 La fragilidad a nivel de población

WP5 Review 

WP5 La fragilidad a nivel de población: una revisión sistemática (Frailty at Population Level a Systematic Review)
Esta revisión resume los datos sobre la prevalencia de la fragilidad, la incidencia, las trayectorias y las transiciones entre las diferentes etapas de fragilidad en los Estados miembros de JA ADVANTAGE (EM). Se investigan las pruebas existentes de programas e intervenciones sistemáticas para el cribado, la vigilancia y el seguimiento de la fragilidad, incluidas las realizadas en el ámbito de la atención primaria, en 22 EM JA ADVANTAGE de la Unión Europea (UE).

 

WP5 1

Galluzzo L, & O’Caoimh R (2018). Preface to Monographic section 'Epidemiology, surveillance and population screening of frailty. Results from the systematic reviews of the European Joint Action ADVANTAGE' Edited by Lucia Galluzzo and Rónán O'Caoimh. Annals of Istituto Superiore di Sanità, 54(3), 223–225.

 

WP5 2 

Galluzzo L, O’Caoimh R, Rodríguez-Laso Á, Beltzer N, Ranhoff AH, Van Der Heyden J, Lamprini-Koula M, Ciutan M, Lopez Samaniego L, Liew A on behalf of Work Package 5 of the Joint Action ADVANTAGE (2018). Incidence of frailty: a systematic review of scientific literature from a public health perspective. Annals of Istituto Superiore di Sanità, 54(3), 239–245.

 

WP5 3

O’Caoimh R, Galluzzo L, Rodríguez-Laso Á, Van Der Heyden J, Ranhoff AH, Lamprini-Koula M, Ciutan M, Lopez Samaniego L, Carcaillon-Bentata L, Kennelly S, Liew A on behalf of Work Package 5 of the Joint Action ADVANTAGE (2018a). Prevalence of frailty at population level in European ADVANTAGE Joint Action

 

WP5 3

O’Caoimh R, Galluzzo L, Rodríguez-Laso Á, Van Der Heyden J, Ranhoff AH, Lamprini-Koula M, Ciutan M, Carriazo AM, Carcaillon-Bentata L, Kennelly S, & Liew A on behalf of Work Package 5 of the Joint Action ADVANTAGE (2018b). Supplementary materials for ‘Prevalence of frailty at population level in European ADVANTAGE Joint Action Member States: a systematic review and meta-analysis’. Annals of Istituto Superiore di Sanità, 54(3), 228-240. 

WP5 5

O’Caoimh R, Galluzzo L, Rodríguez-Laso Á, Van Der Heyden J, Ranhoff AH, Carcaillon-Bentata L, Beltzer N, Kennelly S, & Liew A, on behalf of Work Package 5 of the Joint Action ADVANTAGE (2018). Transitions and trajectories in frailty states over time: a systematic review of the European Joint Action. Annals of Istituto Superiore di Sanità, 54(3), 246–252. 

WP5 6

Rodríguez-Laso Á, O’Caoimh R, Galluzzo L, Carcaillon- Bentata L, Beltzer N, Macijauskiene J, Bacaicoa OA, Ciutan M, Hendry A, Lopez Samaniego L, Liew A, on behalf of Work Package 5 of the Joint Action ADVANTAGE (2018). Population screening, monitoring and surveillance for frailty: three systematic reviews and a grey literature review. Annals of Istituto Superiore di Sanità, 54(3), 253–262. 

 

WP5 D5 2

European Guide for knowing frailty at a population level